ATRX公司
鞋跟
医学
图书馆学
内科学
肿瘤科
生物
生物化学
基因
计算机科学
突变
解剖
出处
期刊:Neuro-oncology
[Oxford University Press]
日期:2023-11-06
卷期号:26 (1): 68-69
标识
DOI:10.1093/neuonc/noad217
摘要
Journal Article SIRT2 inhibition as the Achilles' heel of ATRX-deficient gliomas Get access Şevin Turcan Şevin Turcan Neurology Clinic and National Center for Tumor Diseases, Heidelberg University Hospital and Heidelberg University, 69120 Heidelberg, Germany (Ş.T.) Corresponding Author: Şevin Turcan, PhD, Neurology Clinic and National Center for Tumor Diseases, Heidelberg University Hospital and Heidelberg University, Heidelberg, Germany (sevin.turcan@med.uni-heidelberg.de) https://orcid.org/0000-0002-0885-5607 Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 68–69, https://doi.org/10.1093/neuonc/noad217 Published: 06 November 2023 Article history Published: 06 November 2023 Corrected and typeset: 25 November 2023
科研通智能强力驱动
Strongly Powered by AbleSci AI